Alza's first steps as a FIBCO

Without fanfare, Alza Corp. is quietly building a fully integrated company alongside its royalty-based research boutique.

AZA announced last week that it launched its Testoderm Testosterone Transdermal System, the first transdermal testosterone replacement for hypogonadal males. The product is the first both developed and commercialized by the Palo Alto company in almost 20 years.